Hybio Pharmaceutical Revenue

Hybio Pharmaceutical had revenue of 309.97M CNY in the quarter ending March 31, 2025, with 106.29% growth. This brings the company's revenue in the last twelve months to 749.91M, up 84.97% year-over-year. In the year 2024, Hybio Pharmaceutical had annual revenue of 590.20M with 36.82% growth.

Revenue (ttm)

749.91M

Revenue Growth

+84.97%

P/S Ratio

29.21

Revenue / Employee

724.55K

Employees

1,035

Market Cap

21.90B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	590.20M	158.81M	36.82%
Dec 31, 2023	431.38M	-272.94M	-38.75%
Jan 1, 2023	704.32M	-31.65M	-4.30%
Jan 1, 2022	735.97M	14.25M	1.97%
Dec 31, 2020	721.72M	107.53M	17.51%
Dec 31, 2019	Pro	Pro	Pro
Jan 1, 2019	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
WuXi AppTec	41.48B
Shenzhen Mindray Bio-Medical Electronics	35.59B
Sichuan Biokin Pharmaceutical	5.82B
Aier Eye Hospital Group	21.81B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings